Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 57Lymphoid 52Other hematologic neoplasm 35Genitourinary 30Gynecologic 28Plasma cell 23Breast 21CNS 20Thoracic 14Head & Neck 14Dermatologic 14Sarcoma 13Myeloid 10Endocrine 6Classical hematology 4Other solid neoplasm 3Other 2

Conditions

Obesity 112Neoplasms 43Sexual Dysfunction, Physiological 31Polycystic Ovary Syndrome 27Overweight 18Breast Neoplasms 18Diabetes Mellitus 16Colorectal Neoplasms 16Dyspnea 14Diabetes Mellitus, Type 2 13Obesity, Morbid 12Mucositis 12Constipation 12Depression 11Prostatic Neoplasms 10Lung Neoplasms 10Hypertension 10Pulmonary Disease, Chronic Obstructive 9Non-alcoholic Fatty Liver Disease 9Metabolic Syndrome 9Insulin Resistance 9Motor Activity 8Cardiovascular Diseases 8Renal Insufficiency, Chronic 7Opioid-Induced Constipation 7Heart Failure 7Asthma 7Sarcopenia 6Rectal Neoplasms 6Multiple Myeloma 6

Interventions

Therapeutics 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Recurrence × Other × Clear all
NCT01020604 2013-04-30

PROTECT-Z

AstraZeneca

Completed
1,376 enrolled
GenitourinaryOther

Obesity, Prostatic Neoplasms, Recurrence

NCT00402935 2012-03-20

Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

Case Comprehensive Cancer Center

Withdrawn
LymphoidOtherOther hematologic neoplasm

Congenital Abnormalities, Hodgkin Disease, Infertility, Leukemia, Lymphoma, Recurrence, Sexual Dysfunction, Physiological, Leukemia, Myeloid, Acute, Sexuality, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡